Pom Klementieff

Pom Klementieff

Ask VT AI
View News Summary
  • Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
  • Illegal immigrant sentenced to life for brutal murder of Maryland jogger
  • Epstein controversy fails to impact Trump's approval rating, as public interest in the case drops significantly.
5 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novartis' drug ianalumab meets Phase III endpoints in Sjögren's disease trials, potentially offering the first targeted therapy for this chronic autoimmune disorder.
  • Illegal immigrant sentenced to life for brutal murder of Maryland jogger
  • Epstein controversy fails to impact Trump's approval rating, as public interest in the case drops significantly.
5 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Pom Klementieff